Related Experiment Video

Updated: May 22, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Cardiovascular disease risk in young people with type 1 diabetes

Janet K Snell-Bergeon1, Kristen Nadeau

  • 1Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA. Janet.snell-bergeon@ucdenver.edu

Journal of Cardiovascular Translational Research
|April 25, 2012
PubMed

Insights

Cardiovascular disease (CVD) is a major concern for individuals with type 1 diabetes (T1D). This review highlights key risk factors and early signs of CVD in young T1D patients, emphasizing the need for timely interventions.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Cardiovascular disease (CVD) is the leading cause of mortality in type 1 diabetes (T1D).
  • Effective CVD risk identification in T1D populations remains a significant challenge.
  • Early detection and intervention are crucial for mitigating CVD burden in T1D.

Purpose of the Study:

  • To review established and emerging CVD risk factors in young individuals with T1D.
  • To discuss the current understanding of cardiovascular changes in adolescents with T1D.
  • To explore methods for assessing cardiovascular risk and identify optimal early intervention targets.

Main Methods:

  • Comprehensive literature review of observational studies and clinical trials.
  • Analysis of risk factors including hyperglycemia, dyslipidemia, hypertension, insulin resistance, inflammation, and hypoglycemia.
  • Examination of evidence on cardiovascular function, arterial compliance, and atherosclerosis in T1D.

Main Results:

  • Adverse cardiovascular changes, including atherosclerosis, are evident even in adolescence among T1D patients.
  • Multiple factors contribute to CVD risk, encompassing traditional (e.g., hypertension) and novel (e.g., insulin resistance) elements.
  • Current research aims to define the most effective targets for early intervention.

Conclusions:

  • Early identification of CVD risk factors is critical for individuals with T1D.
  • Interventions targeting hyperglycemia, traditional risk factors, and novel factors like insulin resistance are necessary.
  • Further research is needed to optimize early intervention strategies to reduce CVD in T1D.

More Related Videos

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...